Second Primary Cancer Risks After Breast Cancer in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variant CarriersIsaac Allen, Antonis C. Antoniou, Hend Hassan et al.|Journal of Clinical Oncology|2024Cited by 25
Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variantsLucy Loong, Christopher Bowles, Beth Torr et al.|Genetics in Medicine|2021Cited by 18